Skip to main content

Empliciti Disease Interactions

There is 1 disease interaction with Empliciti (elotuzumab).

Moderate

Elotuzumab (applies to Empliciti) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The use of elotuzumab has been associated with elevations in liver enzymes. Care should be exercised when using this agent in patients with liver impairment. It is recommended to monitor liver enzymes before the start of therapy and periodically as clinically appropriate. Interrupt treatment upon Grade 3 or higher elevation of liver enzymes. After return to baseline values, continuation of treatment may be considered.

References

  1. (2015) "Product Information. Empliciti (elotuzumab)." Bristol-Myers Squibb

Empliciti drug interactions

There are 260 drug interactions with Empliciti (elotuzumab).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer